This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Influence of Cessation of Pomegranate Juice Intake on Inflammation and Oxidative Stress Markers and Glucose Control in Diabetic and Non Diabetic Chronic Hemodialysis Patients

This study has been completed.
Information provided by:
Western Galilee Hospital-Nahariya Identifier:
First received: December 15, 2009
Last updated: August 16, 2011
Last verified: August 2011

The current study will investigate chronic hemodialysis patients who were treated in our unit with pomegranate juice intake for 1 year - compared to a control group.

Markers will be taken 3 months after cessation of pomegranate juice intake, for inflammation and oxidative stress and Hb A1c.

Condition Intervention
Inflammation Oxidative Stress Other: No intervention

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Western Galilee Hospital-Nahariya:

Enrollment: 49
Study Start Date: December 2009
Study Completion Date: August 2011
Groups/Cohorts Assigned Interventions
chronic Hemodialysis patients, treated in our unit. Other: No intervention
chronic Hemodialysis patients , No intervention
chronic Hemodialysis patients, treated in our unit.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
chronic Hemodialysis patients, treated in our unit.

Inclusion Criteria:

  • Chronic Hemodialysis patients three months after termination of study which is currently carried out at our unit; which compared patients taking pomegranate juice three times a week for 1 year to a group that received placebo juice.

Exclusion Criteria:

  • Patients who do not currently participate in above mentioned trial
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01033435

Western Galilee Hospital
Nahariya, Western Galilee, Israel, 25100
Sponsors and Collaborators
Western Galilee Hospital-Nahariya
  More Information

Responsible Party: Dr. Ronit Geron, Deputy Head of Department, Nephrology and Hypertension Department, Western Galilee Hospital, Nahariya Identifier: NCT01033435     History of Changes
Other Study ID Numbers: Gron09
Study First Received: December 15, 2009
Last Updated: August 16, 2011

Keywords provided by Western Galilee Hospital-Nahariya:
Oxidative stress

Additional relevant MeSH terms:
Pathologic Processes processed this record on July 19, 2017